EMA welcomes new Head of International Affairs
EMA is pleased to announce the appointment of Martin Harvey Allchurch as its new head of International Affairs as of 1 October 2021.
Martin Harvey Allchurch brings a wealth of EMA and international experience to this role, having worked in a number of management positions at the Agency, as well as at Unitaid, the World Health Organisation-hosted partnership for access to innovative healthcare in low- and middle-income countries.
He follows Dr Agnès Saint-Raymond in this role, who has retired after 21 years of service. Her departure brings to an end an outstanding career of service to public health in the EU. The Agency acknowledges and thanks her for the remarkable contribution to the work of EMA, most notably in the areas of orphan and paediatric medicines, and international affairs.
An EMA staff member since 1995, Mr Harvey Allchurch is a lawyer by training. His broad international experience includes his significant contribution to promoting the EU-M4all pathway for medicines for use outside the EU, regulatory cooperation in Africa, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and other multilateral partnerships. After an eighteen-month sabbatical with Unitaid, he returned to the Agency in November 2020 to support the EMA leadership of the International Coalition of Medicines Regulatory Authorities (ICMRA), as well as working on bilateral and multilateral projects.